Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas Fidelman

Showing results (11-20 of 111) with videos related to

Pageof 12
Sort By:
Seminars in Liver Disease|March 31, 2021
The Key Role of Staging Definitions for Assessment of Downstaging for Hepatocellular CarcinomaFrancis Y Yao, Nicholas Fidelman, Neil Mehta
Journal of Vascular and Interventional Radiology : JVIR|June 26, 2013
Reply to Re: Hepatotoxicity after transarterial chemoembolization and transjugular intrahepatic portosystemic shunt: do two rights make a wrong?Maureen P Kohi, Nicholas Fidelman, Robert K Kerlan
Hepatology Communications|October 2, 2023
Contemporary applications of Y90 for the treatment of hepatocellular carcinomaQian Yu, Michael Khanjyan, Nicholas Fidelman, et al.
Seminars in Oncology|February 9, 2013
Management of well-differentiated gastrointestinal neuroendocrine tumors metastatic to the liverSam C Wang, Nicholas Fidelman, Eric K Nakakura
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 22, 2013
Factors associated with outcomes and response to therapy in patients with infiltrative hepatocellular carcinomaNeil Mehta, Nicholas Fidelman, Monika Sarkar, et al.
Abdominal Radiology (New York)|April 10, 2021
Frontiers of therapy for hepatocellular carcinomaMichael Heller, Neehar D Parikh, Nicholas Fidelman, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 26, 2011
Mixed hepatocellular cholangiocarcinoma and intrahepatic cholangiocarcinoma in patients undergoing transplantation for hepatocellular carcinomaGonzalo Sapisochin, Nicholas Fidelman, John P Roberts, et al.
Journal of Vascular and Interventional Radiology : JVIR|February 22, 2023
Cost-Effectiveness Analysis of Interventional Liver-Directed Therapies for a Single, Small Hepatocellular Carcinoma in Liver Transplant CandidatesXiao Wu, Michael Heller, Allison Kwong, et al.
Journal of Vascular and Interventional Radiology : JVIR|July 12, 2016
Safety and Efficacy of Doxorubicin Drug-Eluting Embolic Chemoembolization of Hepatocellular Carcinoma Supplied by Extrahepatic Collateral ArteriesR Peter Lokken, Nicholas Fidelman, K Pallav Kolli, et al.
Journal of Vascular and Interventional Radiology : JVIR|December 3, 2013
Percutaneous interventions in failing "necklace" hemodialysis grafts: long-term outcomesAdi J Price, Nicholas Fidelman, Mark W Wilson, et al.
Pageof 12

Showing results (11-20 of 111) with videos related to

Sort By:
Pageof 12
Seminars in Liver Disease|March 31, 2021
The Key Role of Staging Definitions for Assessment of Downstaging for Hepatocellular CarcinomaFrancis Y Yao, Nicholas Fidelman, Neil Mehta
Journal of Vascular and Interventional Radiology : JVIR|June 26, 2013
Reply to Re: Hepatotoxicity after transarterial chemoembolization and transjugular intrahepatic portosystemic shunt: do two rights make a wrong?Maureen P Kohi, Nicholas Fidelman, Robert K Kerlan
Hepatology Communications|October 2, 2023
Contemporary applications of Y90 for the treatment of hepatocellular carcinomaQian Yu, Michael Khanjyan, Nicholas Fidelman, et al.
Seminars in Oncology|February 9, 2013
Management of well-differentiated gastrointestinal neuroendocrine tumors metastatic to the liverSam C Wang, Nicholas Fidelman, Eric K Nakakura
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 22, 2013
Factors associated with outcomes and response to therapy in patients with infiltrative hepatocellular carcinomaNeil Mehta, Nicholas Fidelman, Monika Sarkar, et al.
Abdominal Radiology (New York)|April 10, 2021
Frontiers of therapy for hepatocellular carcinomaMichael Heller, Neehar D Parikh, Nicholas Fidelman, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 26, 2011
Mixed hepatocellular cholangiocarcinoma and intrahepatic cholangiocarcinoma in patients undergoing transplantation for hepatocellular carcinomaGonzalo Sapisochin, Nicholas Fidelman, John P Roberts, et al.
Journal of Vascular and Interventional Radiology : JVIR|February 22, 2023
Cost-Effectiveness Analysis of Interventional Liver-Directed Therapies for a Single, Small Hepatocellular Carcinoma in Liver Transplant CandidatesXiao Wu, Michael Heller, Allison Kwong, et al.
Journal of Vascular and Interventional Radiology : JVIR|July 12, 2016
Safety and Efficacy of Doxorubicin Drug-Eluting Embolic Chemoembolization of Hepatocellular Carcinoma Supplied by Extrahepatic Collateral ArteriesR Peter Lokken, Nicholas Fidelman, K Pallav Kolli, et al.
Journal of Vascular and Interventional Radiology : JVIR|December 3, 2013
Percutaneous interventions in failing "necklace" hemodialysis grafts: long-term outcomesAdi J Price, Nicholas Fidelman, Mark W Wilson, et al.
Pageof 12